Jaguar Health Inc (NASDAQ:JAGX) has a beta value of 0.89 and has seen 15.21 million shares traded in the last trading session. The company, currently valued at $8.43M, closed the last trade at $1.76 per share which meant it lost -$2.51 on the day or -58.78% during that session. The JAGX stock price is -2272.73% off its 52-week high price of $41.76 and -74.43% below the 52-week low of $3.07. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.03 million shares traded. The 3-month trading volume is 799.52K shares.
The consensus among analysts is that Jaguar Health Inc (JAGX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Jaguar Health Inc (NASDAQ:JAGX) trade information
Sporting -58.78% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the JAGX stock price touched $1.76 or saw a rise of 60.27%. Year-to-date, Jaguar Health Inc shares have moved -80.63%, while the 5-day performance has seen it change -57.79%. Over the past 30 days, the shares of Jaguar Health Inc (NASDAQ:JAGX) have changed -55.10%. Short interest in the company has seen 0.31 million shares shorted with days to cover at 0.39.
Jaguar Health Inc (JAGX) estimates and forecasts
Figures show that Jaguar Health Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -71.41% over the past 6 months, with this year growth rate of 94.97%, compared to 13.30% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 86.10% over the past 5 years. Earnings growth for 2024 is a modest 99.36% while over the next 5 years, the company’s earnings are expected to increase by 40.00%.
JAGX Dividends
Jaguar Health Inc is expected to release its next earnings report in August this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
